Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.
about
Medical treatments for autoimmune hepatitisIsolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitisAuto immune hepatitisReview article: the management of autoimmune hepatitis beyond consensus guidelinesDiagnosis and Management of Autoimmune Hepatitis: Current Status and Future DirectionsNon-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.Hormone replacement therapy in chronic active hepatitis; a case report.A Case of Autoimmune Hepatitis Treated with Rituximab.Current status of therapy in autoimmune liver diseaseChronic active hepatitis.Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.Controlled trial of synthetic D-penicillamine and prednisone in maintenance therapy for active chronic hepatitis.Corticosteroids in liver disease: possible mechanisms of action, pharmacology, and rational use.Impaired conversion of prednisone to prednisolone in patients with liver cirrhosis.Autoimmune hepatitis: a review of current diagnosis and treatment.Autoimmune hepatitis. Making sense of all those antibodies.Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of DiseaseManagement of patients with difficult autoimmune hepatitis.Active chronic hepatitis: Part 2Alternate day corticosteroid causes alternate day hyperglycaemiaEpidemiology and treatment of autoimmune hepatitis.Current and future treatments of autoimmune hepatitis.Clinical usefulness of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis.The use of immunosuppression in autoimmune hepatitis: A current literature reviewCurrent trends in the diagnosis and treatment of autoimmune hepatitis in Japan.Autoantibody-negative autoimmune hepatitis.Drug choices in autoimmune hepatitis: part A--Steroids.Drug choices in autoimmune hepatitis: part B--Nonsteroids.Acute and acute severe (fulminant) autoimmune hepatitis.Current and prospective pharmacotherapy for autoimmune hepatitis.Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events.A review of the rational use of corticosteroids.Differential effects of fibroblast and leucocyte interferon in HBsAg positive chronic active hepatitis.D-penicillamine as maintenance therapy for active chronic hepatitis.Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use.Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments.A clinicopathological study of liver disease in haemophiliacs.Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis.Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis.Chronic active hepatitis in children. A clinical and immunological long-term study.
P2860
Q24240280-44D7AE7D-A380-485D-8050-78B4FDE4CD26Q24681787-7EBC74E3-EC6B-47DC-ACAA-60D54625317FQ26746242-56546DF1-1DDB-497A-85BF-E84F5500B02FQ26864272-12946E45-18A6-45A3-BA43-91DAE6A558BFQ28076505-BA550578-EF9B-4E2C-BBC7-7103FDAFCF69Q33447479-A7ED044F-BE3D-4CED-9FD0-4B798AD8F541Q34377693-81FF4E24-2910-4616-8963-5A334B9B1A56Q34394145-32349199-C5A7-47DF-A21D-3C79D4331D8FQ34408950-D0B90214-0024-4E52-9283-F056F2B092C5Q34460416-811CD5C3-692C-4D78-92C4-CB01E05F52C6Q34472161-6930807B-0720-47AA-8120-7039A8297489Q34472334-B7E0032B-8A51-4564-B630-49B110619921Q34476557-4F31D965-FA01-4C4B-A65B-21E43269F657Q34494670-7AD5C710-53F0-4C0B-96C0-EA48F87111ABQ35094267-5216931C-0DE8-44BA-8C81-688556021809Q35182689-92B03623-EF57-4977-8F58-57D486B59234Q35906055-EF971537-1F41-4BBE-8D07-FA7BCB5FCEB4Q36379083-C61D189C-5046-49DB-930E-F74E3E9CF818Q36659925-99149D1C-D8AA-48A4-9047-C44CDE7F942DQ36721791-F98668EA-6AD3-40A3-B779-E6EB90CBC80CQ37356353-F2966846-0FB5-425D-A4C6-149CFD9C4F91Q37503380-E07A60E0-FBD8-41AD-A241-237512000640Q37570952-30DB03D9-BCBD-4EAF-AF26-8FBCEE49B6A6Q37738804-8B6E6B9C-8DD1-4EEF-996B-5CAC00BF993FQ37951701-A3EBD641-6217-4036-94C2-CE796E58CBF5Q37970311-8EADA57E-56A4-4C36-8F0F-567ECB1CE112Q38051705-7450289A-65F4-4B64-85E3-FDD78BEFCA88Q38051706-ED48F37C-77A1-4339-BBBD-28F5CBC0C2D0Q38054513-A2C80785-9416-46C3-8D3F-FD6639AD0290Q38222882-76DF48C1-E6A8-4DA3-8CB2-6C97F0963BD8Q38247488-767994C0-2007-43B0-8006-AC0EA2BFB0ECQ38774602-EF04FB4E-59A9-4D3C-A732-A8033E593D34Q39676787-83576C4A-5E9F-419B-AB29-79C26A522F27Q39726121-BA4510D9-C261-49B2-A63D-676C6DF87716Q41344505-C6AFDF0F-C98D-42EF-B585-172FEAC5DB9DQ42358509-82F2FAA3-2E01-443B-88BE-174E05DF9573Q42850554-EA6B9934-984C-48CA-B100-CB8BE688A282Q43225448-B15C314B-E001-4381-8E2B-F262401D1706Q43933947-EDF978D1-51B5-4646-8F39-BD5A15E69063Q44105623-C6D8645B-48C4-4C3B-B80C-337EC63B002E
P2860
Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.
description
1975 nî lūn-bûn
@nan
1975 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Prednisone for chronic active ...... on with azathioprine compared.
@ast
Prednisone for chronic active ...... on with azathioprine compared.
@en
Prednisone for chronic active ...... on with azathioprine compared.
@nl
type
label
Prednisone for chronic active ...... on with azathioprine compared.
@ast
Prednisone for chronic active ...... on with azathioprine compared.
@en
Prednisone for chronic active ...... on with azathioprine compared.
@nl
prefLabel
Prednisone for chronic active ...... on with azathioprine compared.
@ast
Prednisone for chronic active ...... on with azathioprine compared.
@en
Prednisone for chronic active ...... on with azathioprine compared.
@nl
P2093
P2860
P356
P1433
P1476
Prednisone for chronic active ...... on with azathioprine compared.
@en
P2093
Baggenstoss AH
Summerskill WH
P2860
P304
P356
10.1136/GUT.16.11.876
P407
P577
1975-11-01T00:00:00Z